AM-37 and ST-36 Are Small Molecule Bombesin Receptor Antagonists.

about

AM-37 and ST-36 Are Small Molecule Bombesin Receptor Antagonists.

Item

http://www.wikidata.org/entity/Q41074447

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

AM-37 and ST-36 Are Small Molecule Bombesin Receptor Antagonists.

@en

type

Item

label

AM-37 and ST-36 Are Small Molecule Bombesin Receptor Antagonists.

@en

prefLabel

AM-37 and ST-36 Are Small Molecule Bombesin Receptor Antagonists.

@en

P1476

AM-37 and ST-36 Are Small Molecule Bombesin Receptor Antagonists.

@en

P2093

Irene Ramos-Alvarez

http://www.w3.org/2001/XMLSchema#string

Marcello Leopoldo

http://www.w3.org/2001/XMLSchema#string

Nicole Tashakkori

http://www.w3.org/2001/XMLSchema#string

Paola Moreno

http://www.w3.org/2001/XMLSchema#string

Robert T Jensen

http://www.w3.org/2001/XMLSchema#string

Samuel A Mantey

http://www.w3.org/2001/XMLSchema#string

Terry W Moody

http://www.w3.org/2001/XMLSchema#string

P2860

Two distinct bombesin receptor subtypes are expressed and functional in human lung carcinoma cells

International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states

Identifying activating mutations in the EGFR gene: prognostic and therapeutic implications in non-small cell lung cancer

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

Insights into bombesin receptors and ligands: Highlighting recent advances

Neuromedin B is present in lung cancer cell lines

The lipid-associated 3D structure of SPA, a broad-spectrum neuropeptide antagonist with anticancer properties.

[D-Arg1,D-Trp5,7,9,Leu11]substance P: a novel potent inhibitor of signal transduction and growth in vitro and in vivo in small cell lung cancer cells.

Discovery of a high affinity radioligand for the human orphan receptor, bombesin receptor subtype 3, which demonstrates that it has a unique pharmacology compared with other mammalian bombesin receptors.

Gastrin-releasing peptide receptor mediates activation of the epidermal growth factor receptor in lung cancer cells

P304

176

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FENDO.2017.00176

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28785244

http://www.w3.org/2001/XMLSchema#string

P932

5519534

http://www.w3.org/2001/XMLSchema#string